Clinical trial

SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients…

NCT00002642 · SWOG Cancer Research Network, Other · Completed

Key facts

NCT number NCT00002642
Title SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer
Official title Induction Chemoradiotherapy Followed by Surgical Resection for Non-small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumors): A Phase II Trial
Lead sponsor SWOG Cancer Research Network, Other
Collaborators National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group Cancer and Leukemia Group B NCIC Clinical Trials Group North Central Cancer Treatment Group
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, etoposide, conventional surgery, low-LET cobalt-60 gamma ray therapy
Enrollment 116
Start date Apr 1, 1995
Primary completion Jan 1, 2001
Completion Jul 1, 2004
First posted Jun 30, 2004
Last update posted Oct 8, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies